Delivery Order SPE2DE24DA010-SPE2D625F1EXW
- Not listed
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $5,495 by the Defense Logistics Agency's Medical Supply Chain on July 30, 2025, with an ultimate completion date of August 4, 2025. This delivery order, which contains no set-aside designation indicating full and open competition, represents a call against a larger indefinite delivery contract vehicle. The work will be performed in Santa Clara, California, and involves the...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order (Contract No. 4568634478, GALLANT) by the Medical Supply Chain division of the Department of Defense on June 20, 2025, with an ultimate completion date of June 25, 2025. The contract, valued at $30,281.95, carries no set-aside designation, indicating full and open competition. Performance will occur at Abbott's facility in Santa Clara, California. This delivery order represents a...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order contract valued at $51.3K by the Medical Supply Chain, a defense-focused federal agency, on July 16, 2025. This fixed-price delivery order with economic price adjustment carries an ultimate completion date of July 21, 2025, and will be performed in Santa Clara, California. The contract was awarded under full and open competition with no set-aside designation, indicating Abbott competed against other...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a fixed-price delivery order with economic price adjustment totaling $9,500 by the Defense Logistics Agency's Medical Supply Chain division. The contract, designated as AVEIR and issued on July 29, 2025, with an ultimate completion date of August 1, 2025, will be performed in Santa Clara, California. This delivery order was awarded without set-aside designation, indicating full and open competition among...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $66,000 by the Defense Logistics Agency's Medical Supply Chain on July 31, 2025, with an ultimate completion date of August 5, 2025. The contract, designated as MITRCLIP and issued without set-aside provisions under full and open competition, calls for delivery to Santa Clara, California. This delivery order represents a task order against Abbott's broader federal contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc., a major pharmaceutical and medical device manufacturer, for the delivery of cardiovascular medical devices and related services. The $30,281.95 fixed-price delivery order contract has an ultimate completion date of November 26, 2024. The contract does not include a set-aside designation, indicating full and open competition. Abbott Laboratories Inc., through its Abbott Vascular Inc....
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $8,750 by the Defense Logistics Agency's Medical Supply Chain on August 11, 2025, with an ultimate completion date of August 14, 2025. The contract utilizes a fixed-price pricing structure with economic price adjustment provisions and is not subject to any set-aside designation, indicating full and open competition. The award covers delivery of the AVEIR Leadless Pacemaker to the place...
- This federal contract award was made by the Medical Supply Chain, a division of the Defense agency, to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The $5,695.00 fixed-price with economic price adjustment delivery order contract is for the provision of cardiovascular medical devices and related services to support federal healthcare systems, particularly the Department of Veterans Affairs (VA) and the Defense Logistics Agency (DLA). The contract has an ultimate...
- This federal contract award was made by the U.S. Department of Defense's Medical Supply Chain to Abbott Laboratories Inc.'s Abbott Vascular Inc. division. The $11,750.00 fixed-price delivery order with economic price adjustment has a completion date of June 23, 2025. The contract does not have a set-aside designation, indicating full and open competition. Abbott Laboratories Inc. is a global healthcare company that specializes in medical devices, diagnostic equipment, and pharmaceuticals....
- This federal contract award, valued at $32,006.85, was issued by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc., through its Abbott Vascular Inc. division, to provide cardiovascular medical devices and related services. The contract is a delivery order with a fixed price and economic price adjustment, with a completion date of June 10, 2024. The award is not designated as a set-aside contract, indicating full and open competition. Abbott Laboratories Inc. is a global medical...
- SPE2DE24DA010Indefinite Delivery Contract
- SPE2DE24DA010-SPE2D625F1EXWDelivery Order
Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $25,715.85 by the Defense Logistics Agency's Medical Supply Chain on August 12, 2025, with an ultimate completion date of August 21, 2025. The contract, identified as GALLANT (4569142750), will be performed in Santa Clara, California, and represents a non-set-aside award made through full and open competition. Abbott Vascular specializes in advanced cardiovascular medical technologies, and this delivery order is consistent with the company's established role as a critical supplier of cardiac devices and related products to federal defense healthcare systems. This delivery order leverages Abbott's extensive experience fulfilling federal cardiovascular procurement requirements through the Defense Logistics Agency's broader medical supply chain operations. The fixed-price structure with economic price adjustment pricing reflects the agency's standard approach for medical device procurement. Abbott Vascular's participation in this contract aligns with its substantial track record managing both standalone delivery orders and larger indefinite delivery vehicles for federal medical procurement, including a significant $117.1 million indefinite delivery contract with the DLA for comprehensive cardiovascular procedural packages encompassing devices, instrumentation, and accessories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.7k | 8/12/25 |